Advances in insulin like growth factor binding protein 1 in the prognosis of acute myocardial infarction.
10.3881/j.issn.1000-503X.2011.01.006
- Author:
Lu HUI
1
;
Pan HUI
;
Gong FENG-YING
Author Information
1. Key Laboratory of Endocrinology of Ministry of Health, Department of Endocrinology,PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Insulin-Like Growth Factor Binding Protein 1;
blood;
Insulin-Like Growth Factor I;
metabolism;
Myocardial Infarction;
blood;
Prognosis
- From:
Acta Academiae Medicinae Sinicae
2011;33(1):22-24
- CountryChina
- Language:English
-
Abstract:
Insulin-like growth factor (IGF) is closely associated with cardiovascular diseases. Low IGF-I level and high insulin-like growth factor binding protein-1 (IGFBP-1) level in serum can be used as a marker in predicting the long term morbidity and mortality of acute myocardial infarction (AMI). The article reviews the recent advances in IGFBP-1 in the prognosis of AMI.
